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Abstract
Background: Hantaviruses indigenous to the New World are the etiologic agents of hantavirus cardiopulmonary
syndrome (HCPS). These viruses induce a strong interferon-stimulated gene (ISG) response in human endothelial cells.
African green monkey-derived Vero E6 cells are used to propagate hantaviruses as well as many other viruses. The utility
of the Vero E6 cell line for virus production is thought to owe to their lack of genes encoding type I interferons (IFN),
rendering them unable to mount an efficient innate immune response to virus infection. Interferon l, a more recently
characterized type III IFN, is transcriptionally controlled much like the type I IFNs, and activates the innate immune system
in a similar manner.
Methodology/Principal Findings: We show that Vero E6 cells respond to hantavirus infection by secreting abundant IFNl.
Three New World hantaviruses were similarly able to induce IFNl expression in this cell line. The IFNl contained within virus
preparations generated with Vero E6 cells independently activates ISGs when used to infect several non-endothelial cell
lines, whereas innate immune responses by endothelial cells are specifically due to viral infection. We show further that Sin
Nombre virus replicates to high titer in human hepatoma cells (Huh7) without inducing ISGs.
Conclusions/Significance: Herein we report that Vero E6 cells respond to viral infection with a highly active antiviral
response, including secretion of abundant IFNl. This cytokine is biologically active, and when contained within viral
preparations and presented to human epithelioid cell lines, results in the robust activation of innate immune responses.
We also show that both Huh7 and A549 cell lines do not respond to hantavirus infection, confirming that the cytoplasmic
RNA helicase pathways possessed by these cells are not involved in hantavirus recognition. We demonstrate that Vero E6
actively respond to virus infection and inhibiting IFNl production in these cells might increase their utility for virus
propagation.
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Introduction
Vero E6 cells are epithelioid cells derived from the kidney of
African green monkeys and, with their permissiveness for high
viral productivity, are preferred for the isolation and/or
propagation of the members of several virus families, including
hantaviruses (a genus of the family Bunyaviridae) [1,2,3,4,5,6,7,8].
The utility of these cells for virus propagation is at least three-fold.
First, they are infectable by several diverse viruses, perhaps due to
an abundant receptor repertoire, or non-specific uptake of virus
particles. Second, they have sustained a genetic deletion that
ablated the type I IFN locus [9]. Third, Vero E6-encoded
interferon regulatory factor 3 (IRF3), a transcription factor
necessary for generating responses to virus infection, is relatively
inefficient, resulting in a muted initial response to virus infection
[10]. For experimental purposes, hantavirus infectious stocks
typically consist of the supernatants of infected Vero E6 cells and
are used for in vivo and in vitro experiments.
At the cellular level, virus infection is detected by interactions
between host-encoded pattern recognition receptors (PRRs) and
pathogen-associated molecular patterns (PAMPs). Receptor bind-
ing activates several well-characterized signaling cascades and
results in the activation of type I IFN. More recently, type III IFNs
(IFNl) have been described [11]. These IFNs are comprised of
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and IFNl3 (IL28B). IFNl expression is controlled by pattern
recognition receptor PRR activation, which activates and
mobilizes IRF3 and IRF7, which in turn bind to the interferon-
stimulated response elements (ISREs) of these genes, along with
several other genes. IFNls signal through a heterodimeric cell
surface receptor comprised of IFNLR1 and IL10R2 [12,13].
Expression of the IFNLR1 is cell-type specific, with high
expression in epithelial cells and little or no expression in
endothelial and fibroblast cells, rendering the latter unresponsive
to the effects of IFNl [14,15]. Receptor engagement converges
with that of the type I IFN receptors in that both activate the Jak/
STAT signaling pathway leading to the formation of ISGF3
(STAT1/STAT2/IRF9), a transcription factor that regulates the
expression of several ISGs, including MxA [16,17]. Therefore,
both the expression and function of IFNls is much the same as for
the type I IFNs.
Sin Nombre virus (SNV) and Andes virus (ANDV) are the most
important agents of hantavirus cardiopulmonary syndrome
(HCPS) in North America and South America, respectively
[7,18,19]. HCPS is characterized by pulmonary edema due to
capillary leak, followed by cardiogenic shock. Approximately 500
cases by SNV-related viruses have been reported in the U.S. since
1993 with a 32% case-fatality ratio (www.cdc.gov/ncidod/
diseases/hanta/hps/index.htm). These viruses are carried by
distinct rodent hosts and transmitted to humans by inhalation of
virus-contaminated urine, feces and/or saliva. [20]. Vascular
endothelial cells are thought to be the major site of viral replication
in humans, and infected cells secrete high levels of chemokines and
cytokines as a result [21,22,23,24]. As in many viral systems, it
appears that pathogenic hantaviruses possess mechanisms to
antagonize the innate immune system and this antagonism has
been hypothesized to play a role in the pathogenic process
[25,26,27,28]. For example, Prospect Hill virus (PHV), a New
World hantavirus which has not been identified as a human
pathogen, induces a strong IFN response, whereas the induction
by ANDV is much weaker, likely correlating with their IFN
antagonism efficiencies and possibly their pathogenic potential
[29]. Recent work by our laboratory, as well as others, has
focused on the mechanisms of PAMP-PRR engagement and the
processes involved in antiviral activities and IFN antagonism
[3,29,30,31,32,33,34,35]. Many of these studies have also used
human cell lines to characterize these interactions, including
Huh7, a hepatoma cell line, as well as A549, a lung carcinoma cell
line. Both of these cell lines are deficient in the TLR3 PRR axis
but support hantavirus replication [3,34,36,37].
We have previously demonstrated that SNV can induce a strong
innate immune response in human umbilical vein endothelial cells
(HUVEC) as well as Huh7 cells. We observed several differences
in innate immune activation upon infection with hantaviruses. For
example, we observed a strong innate response in Huh7 despite
blocking virus entry, which was not the observation in HUVEC
[33,34]. Therefore, we hypothesized the recognition mechanisms
differ between endothelial cells and these cell lines and that a viral
surface protein or a soluble mediator of the innate immune
response may be responsible for innate immune stimulation. In
this study we found that Vero E6 cells mount an innate immune
response and secrete IFNl following infection by several
hantaviruses, and were able to show that Vero E6-derived IFNl
is solely responsible for the induction of ISGs in both Huh7 and
A549 cells, whereas ISG stimulation in primary human endothe-
lial cells is virus-specific. This is the first report demonstrating that
Vero E6 cells secrete IFNl in response to viral infection and this
response can in turn elicit downstream biological processes.
Results
SNV stock virus generated in Vero E6 cells activates a
transient ISG response in Huh7 independent of virus titer,
replication or intact particles
We have previously demonstrated that, although both primary
endothelial cells and the hepatoma cell line Huh7 respond to
infection by hantaviruses by up-regulating ISGs, we observed
several differences in cellular entry and transcription factor
requirements that suggested a divergent PAMP and/or PRR axis
had been activated in these distinct cell types [33,34]. Because ISG
inductions were observed in Huh7 in response to SNV stocks
independent of entry and infection, we hypothesized that the ISG-
activating component of the viral stocks may not be associated
with infectious virus or the viral particle itself, but may be a soluble
component derived from either the virus, or the Vero E6 cells used
to propagate the virus. To test our hypothesis, we examined the
kinetics of ISG56 and MxA activation by live SNV and compared
this to viral replication kinetics in Huh7 cells. SNV induced a
strong ISG response upon initial infection, however, this response
was transient and almost completely abated by one day post
infection (dpi), despite the continuous accumulation of viral S-
segment vRNA in Huh7 cells (Figure 1A). We verified that Huh7
cells were productively infected, since we were also able to use
their supernatants to infect fresh Vero E6 cells and focus assays
performed on Vero E6 cells showed titers of up to 10
4 ffu/mL
(data not shown). These results indicate that either the products of
viral replication are not required for ISG stimulation, or that the
virus can efficiently antagonize innate immune responses following
replication, thus inhibiting ISG activation. We then asked whether
the ISG-activating potential in Huh7 is a function of viral titer
upon initial infection. For this, we generated a time-course series of
SNV stocks in Vero E6 cells and assayed both their viral titer on
fresh Vero E6 cells and their ISG-inducing potential on Huh7 cells
(Figure 1B). We observed that ISG induction is dissociable from
the viral titer, with the highest ISG-inducing activity exhibited by
the 20 dpi virus stocks, which had the lowest viral titers. To test
whether a soluble mediator of innate immunity is responsible for
the observed ISG transcription, we examined whether the ISG-
activating fraction is physically dissociable from intact viral
particles by filtration. We applied SNV stocks to a 100-kDa cut-
off Amicon centrifugation filters and collected the filtrate and
retentate, both of which we resuspended to the starting volume by
the addition of cell culture medium. We were unable to detect
replication-competent virus in the filtrate by titration (data not
shown). When these components were applied to Huh7 cells, we
observed that the ISG activating fraction was contained within the
filtrate, indicating that a soluble component derived from the Vero
E6 cell stocks, or viral components of less than 100-kDa relative
mass are responsible for ISG inductions (Figure 1C).
Vero E6 cells secrete IFNl in response to SNV
We screened several human cell lines for their ability to activate
ISG56 and MxA in response to SNV. In most cases, adherent
human cell lines were able to respond, as assessed by their strong
and early induction of expression of these genes. An exception to
this was a HEC 1b cell line that is deficient in Jak/STAT signaling
(kindly provided by Marc Wathelet). Poly (I:C) (50 mg/mL) was
able to induce a strong ISG56 response, but failed to induce MxA,
which requires IFN signaling via Jak1/STAT (Figure 2A). SNV
stocks failed to induce a response in these cells. Both type I and
type III IFNs utilize the Jak1/STAT signaling pathway to exert
their effects. Since Vero E6 cells are unable to express type I IFNs,
we hypothesized that SNV-infected Vero E6 cells express type III
Vero E6 Produce IFNl
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8 dpi and 20 dpi in Vero E6 cells and concentrated on a 3-kDa
filter, after first removing viral particles using a 100-kDa filter. As a
positive control, we spiked Vero E6-conditioned medium with
recombinant human IL29 (rhIL29) prior to concentration. We
were able to detect a band of approximately 32 kDa, correspond-
ing to the known size of IL29 (and the rhIL29 used) in the 20 dpi
sample, as well as the positive control, but not in Vero E6-
conditioned medium alone or in the 8 dpi sample (Figure 2B),
which is consistent with their ISG-inducing potential (Figure 1B).
To test whether the measured titer of SNV from Vero cells is
falsely lowered by the presence of IFNl in viral stocks, we
conducted endpoint titers of virus in a series of twofold dilutions to
determine whether the titers predicted by the more highly-diluted
virus stocks appeared higher than those less diluted, on the
assumption that an inhibitor such as IFNl would become diluted
and less and less effective in blocking focus production at higher
dilutions. We observed that there was no such augmentation in
apparent titer at higher dilution, indicating that routinely-
measured titers are likely not affected by the presence of IFNl
(data not shown).
Divergent hantaviruses induce IFNl secretion in Vero E6
cells
We asked whether IFNl secretion by Vero E6 cells is
specifically induced by SNV, or if IFNl expression is a general
feature of infection by hantaviruses. We compared the cellular
IFNl response to Prospect Hill virus (PHV), a New World
hantavirus thought to be non-pathogenic, to SNV and Andes virus
(ANDV), the primary etiologic agents of HCPS in the New World.
Vero E6 monolayers were infected for equal amounts of
hantavirus (1610
3 ffu) and supernatants were collected at the
indicated time points and used for the detection of IFNl by ELISA
or for virus infection by western blotting of nucleocapsid (N). PHV
Figure 1. SNV stocks induce innate responses in Huh7
independent of titer, replication, and intact virus particles. (A)
Huh7 cells were infected with SNV at an MOI=1 for 1 h. At the time
points indicated, cellular mRNA was isolated and used to quantitate viral
S-segment RNA (right y-axis) and ISG expression (left y-axis) using qRT-
PCR. (B) Vero E6 cells grown in 75 cm2 tissue culture flasks were
inoculated with SNV (10 ffu) for 1 h and supernatants were collected at
the time points indicated on the x-axis. Virus was then titrated on fresh
Vero E6 cells (left y-axis) or used to infect Huh7 cells at equal volumes.
ISG56 and MxA expression was measured by qRT-PCR 3 hpi (right y-axis).
(C) SNV from 20 dpi Vero E6 stocks was applied to a 100-kDa filter and
centrifuged for 10 min. Theretentateandfiltrate was resuspended to the
loading volume and applied to Huh7 cells for 3 h. MxA expression was
then measured using by qRT-PCR of total cellular RNA and compared to
untreatedcontrol(Con)cells. All real-time qRT-PCRresults arereported as
the mean 6 SEM from triplicate biological experiments.
doi:10.1371/journal.pone.0011159.g001
Figure 2. Vero E6-derived SNV stocks induce innate responses
via a Jak/STAT pathway and contain IFNl. (A) Hec 1b Jak/STAT
knockout cells were treated with poly (I:C) (50 mg/mL) or the indicated
stock of virus from Figure 1 at an MOI=1 for 3 h. Total cellular RNA was
isolated and used for qRT-PCR for ISG56 and MxA. Real-time qRT-PCR
results are reported as the mean 6 SEM from triplicate biological
experiments. (B) Medium supplemented with 50 mg/mL of rhIL29, and
SNV derived from Vero E6 8 dpi and 20 dpi were applied to a 100-kDa
filter and centrifuged for 10 min. The filtrate was then applied to a 3-
kDa filter and centrifuged for 30 min. Equal volumes of the retentate
were then used for SDS-PAGE. Western blotting was then performed
using an anti-IL29 antibody.
doi:10.1371/journal.pone.0011159.g002
Vero E6 Produce IFNl
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SNV induced modest levels of IFNl at late time points post
infection (Figure 3A). Mock-infected cultures had low levels of
IFNl for all time points, indicating that the increase in IFNl
secretion is not a result of prolonged cell culture or cell death at
late time points, but is virus-specific. This method for generating
hantavirus stocks using Vero E6 cells is typical and the IFNl
measured in these virus preparations represents the absolute
amount of cytokine contained within a milliliter of a given virus
stock. The low level of IL29 detection in the control samples is
likely due to our substitution of a polyclonal detection antibody to
achieve greater cross reactivity to the African green monkey-
derived cytokine. Western blotting showed an accumulation of N
protein in the supernatants, confirming that Vero E6 cells were
productively infected by all three viruses (Figure 3B).
Activation of ISGs by SNV stocks in Huh7 and A549 is due
to IFNl
Type III IFNs are potent stimulators of the innate immune
response. We suspected that the initial ISG response in Huh7 cells
exposed to SNV stocks (Figure 1A) is due to Vero E6 cell-derived
IFNl. We assayed whether recombinant type III IFNs were able to
induce an ISG response in Huh7 similar to that observed by our
SNV stocks. Both IL29 (IFNl1) and IL28A (IFNl2) induced a
strong, dose-dependent, MxA response in these cells (Figure 4A).
We then analyzed the ability of anti-IL29 or anti-IL28A
neutralizing antibodies to block ISG responses by pre-incubation
with our viral stocks (MOI=1, corresponding to 50uL of viral
stock). Both neutralizing antibodies were able to efficiently inhibit
ISG56 and MxA gene inductions in a dose-dependent manner
(Figure 4B). Because both anti-IL29 and anti-IL28A antibodies
blocked ISG inductions almost completely at the highest concen-
trationsused (10 mg/mL),weassayedwhethertheseantibodiescross
react by blocking recombinant IL28A and IL29 respectively, and
found that both antibodies cross reacted well with exogenous IFNl
proteins as measured by their ability to neutralize ISG activation in
Huh7 cells (data not shown). As a control for antibody specificity
and type III IFN sensitivity, we used recombinant IFNb along with
anti-IFNb neutralizing antibodies and observed that although
recombinant IFNb induces a robust ISG response, the anti-IFNb
neutralizing antibody only inhibited recombinant IFNb-mediated
ISG responses, and not inductions by the SNV stock containing
IFNl, indicating that the anti-IFN antibodies are neutralizing only
their homologous targets (Figure 4C). Along with Huh7, A549 cells
are commonly used in hantavirus research and this human lung
carcinoma cell line has been used to study innate immune responses
in the context of infection by hantavirus [3,35,38,39]. We asked
whether this cell type isable to respond toSNVparticles themselves,
or whether ISG responses in A549 cells are attributed to the IFNl
contained within Vero E6-generated stocks. Similar to Huh7 cells,
pre-incubation of SNV stocks with anti-IFNl antibodies completely
inhibited ISG responses observed in A549 when exposed to SNV
particles at an early time point (Figure 4D).
HUVEC respond specifically to SNV but not to IFNl
Endothelial cells are major target of hantaviruses in vivo and lack
the IL28Ra receptor, which renders them incapable of responding
to IFNl [14]. We, as well as other groups, have reported that
primary endothelial cells respond to hantavirus infection by up-
regulating ISGs. We asked whether IFNl contained within our
viral stocks might play a role in ISG responses in HUVEC as they
do in Huh7 and A549. We found that HUVEC transcribe only
very low levels of ISG56 and MxA when exposed to either rhIL29
or rhIL28A. Furthermore, pre-incubation of SNV stocks with
IL29 and IL28A neutralizing antibodies at doses shown to block
IFNl-mediated ISG induction in Huh7 and A549 cell lines, did
not inhibit their ability to respond to SNV (Figure 5). This is
consistent with our previous observations that HUVEC responses
to SNV are specific, as SNV-specific neutralizing antibodies
completely blocks ISG responses to virus [33].
Figure 3. Divergent hantaviruses induce IFNl in Vero E6 cells independent of virus replication. Vero E6 cells were grown in 75 cm
2
culture flasks and infected with 10
3 ffu of PHV, SNV or ANDV for 1 h, or left untreated (Con). Supernatants were collected at the indicated time points
post infection and total medium was replaced. (A) Equal volumes of supernatants were used in an ELISA to detect IL29. Error bars represent the
standard deviation between duplicate ELISA experiments. (B) Equal volumes of supernatants were used for SDS-PAGE followed by western blotting.
Membranes were probed with an anti-hantavirus N antibody.
doi:10.1371/journal.pone.0011159.g003
Vero E6 Produce IFNl
PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e11159Discussion
Herein, we report that Vero E6 cells can recognize viruses and
respond by secreting IFNl. The Vero E6 cell line lacks the ability to
transcribe type I IFNs as they possess a genetic deletion that ablates
the entire type I IFN gene complex on both chromosomes [9]. In
addition, it has recently been shown that these cells mount a weak
initial IRF3-dependent response to various ligands, which partially
accounts for their overall weak innate response to viruses and causes
them to be extraordinarily competent for propagating several virus
typestohigh titers[10].TypeIIIIFNsaretranscribed independently
of type I IFNs, and their activities are conferred through a different
heterodimeric receptor, although both IFNs activate Jak/STAT
signaling pathways and therefore their expression results in the
transcription of a similar subset of ISGs. The quantity of IFNl thus
produced is sufficient to have a dramatic biological effect upon
human cells. Different hantaviruses elicit different levels of
expression of IFNl, although all of the viruses that we tested
induced the secretion of biologically active IFNl in Vero E6 cells.
Hantaviruses primarily infect endothelial cells of the microvas-
culature and recent advances in the understanding of the innate
immune response have prompted laboratories to study early events
in viral recognition and host gene expression. Because primary
cells are difficult to manipulate, several labs, including ours, have
turned to established cell lines for use as a more tractable system
for studying viral recognition and innate immune responses to
infection. Many of these cell lines are of epithelial origin and
express receptors for IFNl. As a consequence, IFNl secreted by
Vero E6 cells used to generate viral stocks can cross species and
dramatically alter innate gene expression. Herein, we demonstrate
that this is true for both the Huh7 and A549 cell lines, which are
the two cell lines most commonly used to study the interactions
between hantaviruses and human host-cells in in vitro systems. We
also confirm herein that innate immune studies performed using
cells of endothelial origin are largely unaffected by IFNl carryover
from Vero E6 cells. These observations are in accordance with our
previous studies showing that endothelial cell responses to
hantaviruses vary according to viral serotype and rely on viral
entry, in contrast to our observations regarding Huh7 cells
[33,34].
An unexpected observation was that Huh7 as well as A549 cells
were completely unresponsive to SNV (as well as PHV and ANDV
Figure 4. Innate responses to SNV in Huh7 and A549 are specifically due to Vero E6-derived IFNl. Total cellular RNA was isolated from
Huh7 or A549 cells and used for ISG quantitation by qRT-PCR. (A) Huh7 were treated with SNV (50 mL of virus) or the indicated amount of recombinant
human IL29 or IL28A for 3 h prior to MxA mRNA quantitation by qRT-PCR. (B) Huh7 were infected with SNV at an MOI=1 (50 mL) with or without prior
incubation with anti-IL29 or anti-IL28A antibodies at the indicated final concentrations for 1 h. Three hours post infection, ISG56 and MxA mRNA
expression was measuredbyqRT-PCR. (C)SNV orIFNb waspreincubatedwith the indicatedamount ofanti-IFNb antibodyfor1 h.Virusor IFNb was then
added to Huh7 cells for 3 h and ISG56 and MxA was measured 3 h post exposure by qRT-PCR. (D) A549 were infected with SNV at an MOI=1, with or
without prior incubation with anti-IL29 blocking antibodies (10 mg/mL). Three hours post infection ISG56 and MxA levels were measured by qRT-PCR.
Real-time qRT-PCR results for all experiments (parts A–D) are reported as the mean 6 SEM from triplicate biological experiments.
doi:10.1371/journal.pone.0011159.g004
Vero E6 Produce IFNl
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elicit ISG activation. Blockage of signaling by Vero-derived IFNl
using antibodies that neutralize type III IFN completely abrogated
the ISG response to virus stocks. Furthermore, despite continuous
and high level of SNV viral replication, Huh7 cells never respond
by upregulation of ISG56 or MxA, which are markers of
activation of the IRF3 and Jak/STAT pathways respectively.
These observations are in contrast to a recent report that Huh7
and A549 cells respond to hantaviruses by up regulating ISGs [3].
In the aforementioned study, both Huh7 and A549 cells mounted
a strong and early MxA response when exposed PHV as compared
to Hantaan virus (HTNV). We observe that stocks of PHV (12dpi)
contain high levels of IFNl, whereas the SNV and ANDV stocks
contain less IFNl for a given time point. It is possible that in their
system, undetected Vero E6-derrived IFNl induced by PHV and
contained within virus preparations might account for their
finding that PHV induces a robust and early innate response
when compared to HTNV.
We observe levels of IFN lambda in hantavirus preparations
that are sufficient to activate an ISG response when presented to
epithelioid cells at a volume corresponding to less than an
MOI=1. This MOI represents approximately 50uL of SNV stock
when used to infect near-confluent cells grown in 24-well plate
format, and a greater volume of virus stock for both ANDV and
PHV, as these viruses typically grow to a lower titer. Interestingly,
we observe that this IFNl is highly stable, especially compared to
the type I IFNs. We were able to detect high levels of IFNl by
ELISA following 5 megarads of gamma irradiation (Fig. 3). We
also observe little or no decline in the biological activity of IFNl
following UV-inactivation of virus preparations, one freeze-thaw
cycle, or storage at 4C for up to one month (data not shown).
The lack of innate immune responsiveness to hantaviruses,
independent of IFNl, by Huh7 cells suggests that the PRR
responsible for recognition of these hantaviruses, at least for SNV,
is not RIG-I or Mda5, confirming our previous observations [34].
Huh7 cells, along with A549 cells possess intact RNA helicase
pathways, but are unable to mount a TLR3-mediated response to
several high titer replicating viruses [36,37]. It is unlikely that this
unresponsiveness presented herein is attributed to a virus-encoded
interferon antagonist that is efficient enough to completely
suppress ISG transcription, as this is not the observation when
using endothelial cells. In support of our evidence that RIG-I is not
the PRR used to detect hantaviruses, recent work has shown that
RIG-I recognizes RNAs with 59 triphosphate groups [40]. In this
study, HTNV was shown to be sensitive to a 59 monophosphate-
specific exonuclease, suggesting a post-transcriptional modification
of the RNA might be a strategy used by hantaviruses to avoid
recognition by RIG-I [40]. Our data also suggests that Vero E6
cells possess an intact hantavirus-sensing PRR and IRF3 pathway.
The delayed and prolonged IFNl activation that we observe is
likely due to the recently characterized weak endogenous Vero E6
IRF3 transcription factor as well as an impaired positive feedback
amplification of the innate response due to the lack of type I IFNs
[10]. These inherent characteristics, taken together with their
ability to mount a type III IFN response, might lend Vero E6 cells
particularly useful for examining the signaling events of early
innate responses, and IFN antagonism, by hantaviruses, as well as
other virus families.
Our finding that PHV can induce a stronger and earlier IFNl
response in Vero E6 cells is not surprising. HCPS-causing
hantaviruses have been shown to induce a weak IFN response,
whereas PHV induces IFNs much more readily [29]. This is likely
due to an antagonistic capability of SNV and ANDV upstream of
IFN activation. The isolate of ANDV we are using consistently
replicates to lower titers than does the SN77734 isolate of SNV,
although here we show that both viruses activate a similar IFNl
profile. This is possibly due to individual differences in their
antagonistic potential in conjunction with their replicative fitness.
Conversely, the profile of IFNl induced by PHV in Vero E6 cells
reinforces the observations that IFN antagonism by this virus is less
efficient.
The modulation of IFNl by hantaviruses may have clinically
relevant implications. Interestingly, IFNl expression has been
observed to be important for human hantavirus infection in vivo.
Patients infected with Puumala virus and presenting with
nephropathia epidemica (NE) had significantly lower serum levels
of IFNl during acute infection compared with healthy control
patients. In vitro, HTNV virus replication is inhibited in cells
pretreated with IFNl, although post infection treatment does not
inhibit replication [38]. Furthermore, it has recently been shown
that dendritic cells treated with IFNl, but not type I IFNs, are able
to polarize T cells to a Foxp3
+ expressing tolerogenic phenotype,
indicating that IFNl might skew the immune system toward an
anti-inflammatory response [41]. The natural host and reservoir
for SNV is the deer mouse, which becomes persistently infected
and displays little or no pathology [42]. CD4
+ T cells from
persistently infected deer mice display a Foxp3
+ phenotype,
indicative of T regulatory cells, and this may be a mechanism in
which the deer mouse avoids an inflammatory-mediated patho-
genic state [43]. The mechanism of the T cell regulation is
currently unknown, but IFNl might play a role in generating the
observed suppressive response. The link between cell culture
production of IFNl and in vivo IFNl expression, and its
importance in the pathogenic process of hantavirus infection will
need to be investigated further.
The activation of IFNl by Vero E6 cells demonstrates that these
cells mount an innate immune response to viral infection. The
IFNl response in Vero E6 is likely delayed because of their
inherently weak IRF3 response and lack of type I IFN genes. This
ISG response almost certainly affects the quality and quantity of
viral stocks generated in this system. The onset of IFNl
production in response to hantaviruses correlates with a decrease
in viral titers for all viruses tested, suggesting that these cells enter
an anti-viral state, albeit inefficiently. Disruption of this innate
Figure 5. Endothelial cells specifically respond to SNV and are
refractory to IFNl. HUVEC were treated with SNV at an MOI=1 (50 mL
of stock virus), rhIL29 (50 ng/mL), rhIL28A (50 ng/mL), or left untreated
(con) with or without pre-incubation with the indicated neutralizing
antibody for 1 h. Cellular RNA was used to quantitate ISG expression
3 h post exposure. Real-time qRT-PCR results are reported as the mean
6 SEM from triplicate biological experiments.
doi:10.1371/journal.pone.0011159.g005
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propagating virus stocks. This work has implications for all systems
utilizing Vero E6-derived virus preparations and furthers the field
of innate immunity to hantaviruses.
Materials and Methods
Cells, viruses and reagents
We purchased human hepatoma cells (Huh7) from Apath (New
York). A549 and Vero E6 cells were purchased from ATCC. We
grew cells in DMEM (Invitrogen) containing 10% FCS, 1X
essential amino acids (Gibco), pen/strep, and gentamicin. We
purchased pooled primary human umbilical vein endothelial cells
(HUVEC), from Clonetics (San Diego, CA) and propagated them
in EBM-2 medium supplemented with the Clonetics bullet kit,
which supplies growth factors including vascular endothelial
growth factor (VEGF). We previously described the isolation of
Sin Nombre virus (SNV) strain SN77734 from a New Mexico deer
mouse [42]. We obtained Andes virus (ANDV) strain CHI-7931
from H. Galeno, Instituto Salud Publico, Santiago, Chile and
Prospect Hill virus (PHV) strain PH-1 from R. Yanagihara (Univ.
of Hawaii). Hantaviruses were propagated and titrated on Vero E6
cells (ATCC) under strict standard operating procedures using
biosafety level 3 (BSL3) facilities and practices (CDC registration
number C20041018-0267).
For virus infections, we seeded cells in 48- or 24-well plates at a
density to achieve 90–95% confluence after overnight incubation
at 37uCi n5 %C O 2. Treatment was done essentially as described
previously [33].
For antibody blocking studies, we incubated viruses or
recombinant proteins with the indicated concentrations of anti-
IL29, anti-IL28A, or anti-IFNb (R&D Systems, AF1598, AF1587
or AF814, respectively) for 0.5 h at room temp. The resulting
mixture was then added to cells and incubated for 3 h prior to
performing the indicated assays. Recombinant proteins used
included rhIL29, rhIL28A and rhIFNb (R&D Systems, 1598-IL-
025, 1587-IL-025 and 11415-1, respectively).
For poly (I:C) treatment, we seeded cells as above and at the
time of infection, and exposed cells to 10% DMEM containing
50 mg/mL poly (I:C) (Sigma).
Virus titrations
We infected monolayers of Vero E6 cells grown in 24-well plates
with 200 mL of serial 10-fold diluted virus for 2 h. We then
removed the inoculum and overlaid the cells with a 1.2% solution
of methylcellulose in a final concentration of 1X DMEM, 2.5%
FBS. The cells were incubated for seven days prior to staining for
foci using a rabbit polyclonal anti-N antibody followed by the
addition of a 1:1000 dilution of an HRP-conjugated anti-rabbit-
antibody (Jackson ImmunoResearch). Foci were developed using a
metal-enhanced DAB substrate kit (Thermo Scientific).
Real-Time SYBR Green and TaqMan RT-PCR
For SYBR Green RT-PCR, we performed reverse transcription
using 2 mg of total RNA extracted from cell cultures using the
RNeasy kit (Qiagen) in 40 mL reactions using the Applied
Biosystems TaqMan Reverse Transcription reagents kit (ABI,
Foster City, CA). For PCR, we used the Applied Biosystems Power
SYBR Green reagents kit to perform reactions in triplicate using
3 mL of cDNA and a 0.4 mM final concentration of each primer in
a2 5mL total reaction volume. The primers we used were specific
for: b-actin, sense (59-ccatcatgaagtgtgacgtgg-39) and antisense (59-
gtccgcctagaagcatttgcg-39); ISG56, sense (59-tctcagaggagcctggctaag-
39) and antisense (59-ccacactgtatttggtgtctagg-39); MxA, sense (59-
tgatccagctgctgcatccc-39) and antisense (59-ggcgcaccttctcctcatac-39).
We calculated the fold-change for each gene using the mean of the
change in CT values (DCT) normalized to the CT values of
GAPDH for each sample (2
2DDCt) [33].
We performed TaqMan RT-PCR for SNV viral S-segment
RNA as previously described [33]. We quantified the viral RNA
using a standard curve generated using S-segment templates of
known copy number.
Supernatant filtration
We added 1 mL of the Vero E6-derived virus stocks to 100-kDa
filtration units (Amicon) and centrifuged them at 40006g for
15 min. The retentates and filtrates were resuspended to a final
volume of 1 mL and equal volumes were added to Huh7 cells. For
the samples used to detect IL29 by western blotting, we applied the
filtrate of 100-kDa filter units to 3-kDa filter units (Amicon) and
centrifuged them at 40006g for 45 min. The retentate was then
used directly in assays for ISG induction.
Western blotting
For IL29 detection, we boiled the retentates of the 3-kDa
filtration units along with a 4% SDS loading buffer for 5 min. We
then separated retentates on a 12.5% SDS-PAGE gel and
transferred the proteins to PVDF membranes. Membranes were
then probed with a primary polyclonal rabbit anti-IL29 antibody
(R&D Systems) overnight at 4C at a concentration of 0.2 mg/mL
followed by an incubation with a 1:10,000 dilution of a HRP-
labeled anti-rabbit IgG secondary antibody for 1 h (Jackson
ImmunoResearch). For hantavirus N detection, we used the
methods described previously [34].
ELISA of IL29
We performed ELISA using the human IL29 DuoSet ELISA
Development System (R&D Systems, DY1598) as per their
recommended protocol, with the exception of coating the plates
with a polyclonal anti-human IL29 capture antibody (R&D
Systems, AF1598). This antibody was used for its greater
crossreactivity to African green monkey-derived IFNl. We added
100 mL of Vero E6-derived viral stocks that had been subjected to
5 megarads of gamma irradiation, or Vero E6-conditioned
medium as a control. The concentrations of IL29 were interpreted
from a curve generated using 2-fold dilutions of a recombinant
IL29 standard starting at 8000 pg/mL. All data were reported as
the average of samples and standards run in duplicate wells.
Statistical analysis Statistical analyses were performed on
replicate samples using an unpaired Student’s t test. The mean 6
standard error of the mean is represented and significance
(P,0.05) is reported where appropriate.
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